United Kingdom· GB-APID-7531411000001106
Fibrazate XL 400mg tablets
A bezafibrate product containing bezafibrate, registered in United Kingdom by Sandoz Ltd. The same ATC class is registered in 10 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Bezafibrate is registered in 10 of 19 countries.
Countries holding a registration under ATC C10AB02 (bezafibrate), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 6 of them publish a price we can compare per daily dose
Bezafibrate · ATC C10AB02
10 / 19 countries
- Belgiumprice
- Canada
- Finlandprice
- Franceprice
- Germany
- Italyprice
- Netherlands
- Norwayprice
- Switzerlandprice
- United Kingdom
Price per daily dose
What a daily dose of bezafibrate costs, country by country.
Normalised to the WHO defined daily dose (0.6 g), the median price runs from $0.29 in France to $1.19 in Switzerland — a ×4.1 gap.
- 3 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Bezafibrate · price per daily dose (0.6 g)
USD · FX 28 Sept 2026
- CH Switzerland$1.19
- IT Italy$0.44
- FR France$0.29
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Bezafibrate
- Manufacturer
- Sandoz Ltd
- Country
- United Kingdom (GB)
- ATC code
- C10AB02
- ATC class
- Bezafibrate
- Defined daily dose
- 0.6 g, O
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 1
- gtin05015915879035
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Bezafibrate in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- NetherlandsBezalip Retard 400 mg, tabletten met gereguleerde afgifteEU-Pharma B.V.
- FinlandBezafibrat GenericsGenerics (UK) Limited
- NorwayBezalip RetardAurobindo Pharma
- SpainDIFATEROL RETARD 400 mg COMPRIMIDOS DE LIBERACION PROLONGADALaboratorios Bial S.A.
- CanadaBEZALIP SRALLERGAN INC
- SwedenBezalip Retard 400 mg DepottablettActavis Group PTC ehf.
- FranceBEFIZAL L.P. 400 mg, comprimé enrobé à libération prolongéeARROW GENERIQUES
- BelgiumEulitop 400 mgAurobindo
Authorised across Europe · EMA
The same active substance is authorised in 14 EEA countries. Names it is sold under:
- Austria · Bezalip Retard, Bezastad
- Belgium · Cedur, Eulitop
- Cyprus · Lacromid, Zafibral
- Germany · Bezafibrat Al, Bezafibrat Retard Al
- Spain · Eulitop, Eulitop Retard
- Finland · Bezalip
- France · Befizal, Befizal L.P.
- Hungary · Bezalip
- Italy · Bezalip
- Luxembourg · Cedur, Eulitop
- Netherlands · Bezafibrate Aurobindo
- Portugal · Bezalip, Bezalip Retard
- Romania · Bezafibrat Arena
- Sweden · Bezalip, Bezalip Retard
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b951f9cb-e1a2-4a6c-84a5-dee6c12db632 GET /v1/drugs/b951f9cb-e1a2-4a6c-84a5-dee6c12db632?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "7531411000001106",
"desc": "Fibrazate XL 400mg tablets (Sandoz Ltd)",
"form": "Modified-release tablet",
"vpid": "39020211000001107",
"source": "dmd",
"vtm_id": "774852009",
"strength": "400 mg",
"substance": "Bezafibrate",
"ingredient": "Bezafibrate",
"supplier_code": "2074301000001102"
}See everything about bezafibrate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.